These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35697402)

  • 1. A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Pereira-Sanchez V; Robles-Ramamurthy B
    Child Adolesc Psychiatr Clin N Am; 2022 Jul; 31(3):569-581. PubMed ID: 35697402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guidelines for attention-deficit/hyperactivity disorder: a review.
    Bukstein OG
    Postgrad Med; 2010 Sep; 122(5):69-77. PubMed ID: 20861590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review.
    Amer YS; Al-Joudi HF; Varnham JL; Bashiri FA; Hamad MH; Al Salehi SM; Daghash HF; Albatti TH;
    PLoS One; 2019; 14(7):e0219239. PubMed ID: 31276528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.
    Young S; Hollingdale J; Absoud M; Bolton P; Branney P; Colley W; Craze E; Dave M; Deeley Q; Farrag E; Gudjonsson G; Hill P; Liang HL; Murphy C; Mackintosh P; Murin M; O'Regan F; Ougrin D; Rios P; Stover N; Taylor E; Woodhouse E
    BMC Med; 2020 May; 18(1):146. PubMed ID: 32448170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Practice Guidelines for the Evaluation and Diagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A systematic review of the literature.
    Razzak HA; Ghader N; Qureshi AA; Zafar M; Shaijan JF; Al Kuwari M
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e12-e21. PubMed ID: 33777419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder.
    Seixas M; Weiss M; Müller U
    J Psychopharmacol; 2012 Jun; 26(6):753-65. PubMed ID: 21948938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
    Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
    Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics.
    Pediatrics; 2000 May; 105(5):1158-70. PubMed ID: 10836893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Greenhill LL; Crismon ML; Sedillo A; Carlson C; Conners CK; McCracken JT; Swanson JM; Hughes CW; Llana ME; Lopez M; Toprac MG
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):908-19. PubMed ID: 10892234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality Assessment of Clinical Practice Guidelines Developed by Professional Societies in Turkey.
    Yaşar I; Kahveci R; Baydar Artantaş A; Ayhan Başer D; Gökşin Cihan F; Şencan I; Koç EM; Özkara A
    PLoS One; 2016; 11(6):e0156483. PubMed ID: 27295303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to diagnosis and management of childhood attention deficit hyperactivity disorder.
    Jerome D; Jerome L
    Can Fam Physician; 2020 Oct; 66(10):732-736. PubMed ID: 33077449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: a practical approach based upon expert consensus.
    Young S; Gudjonsson G; Chitsabesan P; Colley B; Farrag E; Forrester A; Hollingdale J; Kim K; Lewis A; Maginn S; Mason P; Ryan S; Smith J; Woodhouse E; Asherson P
    BMC Psychiatry; 2018 Sep; 18(1):281. PubMed ID: 30180832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.